Newsflash

Press Release – NEURO-BIO ATTRACTS OVER $3 MILLION IN SERIES A INVESTMENT TO DEVELOP A NEW APPROACH TO ALZHEIMER’S DISEASE Click here for the Neuro-Bio press release

Neuro-Bio’s Novel Therapeutic Candidates

By building on its’ unique insight into the underlying mechanism triggering neurodegeneration Neuro-Bio can offer a first-of-its-kind solution to effectively treat neurodegenerative conditions such as Alzheimer’s Disease, Parkinson’s Disease and Motor Neuron disease.

The Company has developed an innovative method to intercept and halt action of the toxic AChE-peptide on the receptor to arrest further cell death. By using a range of novel molecules the Company has designed based on the active part of the AChE-peptide the Company has shown that the action of the toxic molecule can be blocked and the neurodegenerative cycle halted.

Neuro-Bio is working with a number of these Intellectual-Property protected, novel agents and will be looking for commercial partners to progress these through the drug development process.